Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's State FDA Gets WHO Nod For Vaccine Regulatory System; Opens Global Market For Chinese Vaccine Makers

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's State FDA now complies with international standards for vaccine regulation and Chinese vaccine makers are eligible to apply for World Health Organization prequalification of vaccine products, WHO announced March 1, the same day that China implemented its newly revised good manufacturing practices (GMP) guidelines
Advertisement

Related Content

A Closer Look: With Only 60% Of China’s Sterile Drug Makers Passing New GMP Standard, What’s Next?
China Releases New, Stricter Vaccine GCP Regulations
First Made-In-China Vaccine Gets WHO-Prequalification Setting The Stage For A New Global Player
China Within Reach Of First WHO Vaccine Prequalification
China's Medical Exports And Imports Nearly Double In First Half 2011
Chinese Manufacturers Will Cut Into India's Vaccine Exports Unless Indian Firms Can Find New Approach - World Vaccine Congress Asia
Fidelity Growth Partner Asia's Norman Chen On Being An Active Investor In China: An Interview With PharmAsia News (Part 2 of 2)
China Releases New Drug GMPs; Domestic Consolidation Expected To Accelerate
China Releases New Drug GMPs; Domestic Consolidation Expected To Accelerate
Leading Chinese Vaccine Developer Sinovac Conducts Technical Exchanges With Gates Foundation On Rotavirus Vaccine
Advertisement
UsernamePublicRestriction

Register

SC077587

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel